{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:32:20Z","timestamp":1778013140020,"version":"3.51.4"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04490-4","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:21:01Z","timestamp":1767028861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantification of the IgG antibody response half-life for hybrid immunity to SARS-CoV-2"],"prefix":"10.1186","volume":"23","author":[{"given":"Felicia","family":"Bongiovanni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eamon","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Cumming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Mazhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Kiernan-Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily M.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie","family":"McVernon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"1","key":"4490_CR1","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1093\/cid\/ciac262","volume":"75","author":"S Gazit","year":"2022","unstructured":"Gazit S, Shlezinger R, Perez G, Lotan R, Peretz A, Ben-Tov A, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study. Clin Infect Dis. 2022;75(1):e545\u201351. https:\/\/doi.org\/10.1093\/cid\/ciac262.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4490_CR2","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","volume":"24","author":"AM Wendelboe","year":"2005","unstructured":"Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(5):S58\u201361. https:\/\/doi.org\/10.1097\/01.inf.0000160914.59160.41.","journal-title":"Pediatr Infect Dis J"},{"key":"4490_CR3","doi-asserted-by":"publisher","unstructured":"Zimmermann P, Curtis N. Factors that influence the immune response to vaccination. Clin Microbiol Rev. 2019(2). https:\/\/doi.org\/10.1128\/cmr.00084-18.","DOI":"10.1128\/cmr.00084-18"},{"key":"4490_CR4","doi-asserted-by":"publisher","unstructured":"Bianchi FP, Mascipinto S, Stefanizzi P, De\u00a0Nitto S, Germinario C, Tafuri S. Long-term immunogenicity after measles vaccine vs. wild infection: an Italian retrospective cohort study. Human Vaccines & Immunotherapeutics. 2021;17(7):2078\u20132084. https:\/\/doi.org\/10.1080\/21645515.2020.1871296.","DOI":"10.1080\/21645515.2020.1871296"},{"issue":"2","key":"4490_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s40121-022-00753-2","volume":"12","author":"N Pooley","year":"2023","unstructured":"Pooley N, Abdool Karim SS, Combadi\u00e8re B, Ooi EE, Harris RC, El Guerche SC, et al. Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review. Infectious Diseases and Therapy. 2023;12(2):367\u201387. https:\/\/doi.org\/10.1007\/s40121-022-00753-2.","journal-title":"Infectious Diseases and Therapy"},{"issue":"1","key":"4490_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29225-4","volume":"13","author":"L P\u00e9rez-Al\u00f3s","year":"2022","unstructured":"P\u00e9rez-Al\u00f3s L, Armenteros JJA, Madsen JR, Hansen CB, Jarlhelt I, Hamm SR, et al. Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors. Nat Commun. 2022;13(1):1614. https:\/\/doi.org\/10.1038\/s41467-022-29225-4.","journal-title":"Nat Commun"},{"key":"4490_CR7","doi-asserted-by":"publisher","unstructured":"Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman LS, Ash N, et\u00a0al. Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2. New England Journal of Medicine. 2022;386(23):2201\u20132212. Publisher: Massachusetts Medical Society. https:\/\/doi.org\/10.1056\/NEJMoa2118946.","DOI":"10.1056\/NEJMoa2118946"},{"issue":"12","key":"4490_CR8","doi-asserted-by":"publisher","first-page":"e944","DOI":"10.1016\/S2666-5247(22)00287-7","volume":"3","author":"H Chemaitelly","year":"2022","unstructured":"Chemaitelly H, Ayoub HH, AlMukdad S, Coyle P, Tang P, Yassine HM, et al. Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study. Lancet Microbe. 2022;3(12):e944\u201355. https:\/\/doi.org\/10.1016\/S2666-5247(22)00287-7.","journal-title":"Lancet Microbe"},{"issue":"8","key":"4490_CR9","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.jiph.2023.05.018","volume":"16","author":"M Franchi","year":"2023","unstructured":"Franchi M, Pellegrini G, Cereda D, Bortolan F, Leoni O, Pavesi G, et al. Natural and vaccine-induced immunity are equivalent for the protection against SARS-CoV-2 infection. J Infect Public Health. 2023;16(8):1137\u201341. https:\/\/doi.org\/10.1016\/j.jiph.2023.05.018.","journal-title":"J Infect Public Health"},{"issue":"7","key":"4490_CR10","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/cid\/ciab608","volume":"74","author":"SF Lumley","year":"2022","unstructured":"Lumley SF, Rodger G, Constantinides B, Sanderson N, Chau KK, Street TL, et al. An observational cohort study on the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status. Clin Infect Dis. 2022;74(7):1208\u201319. https:\/\/doi.org\/10.1093\/cid\/ciab608.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"4490_CR11","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/aje\/kwac060","volume":"191","author":"Y Goldberg","year":"2022","unstructured":"Goldberg Y, Mandel M, Woodbridge Y, Fluss R, Novikov I, Yaari R, et al. Similarity of protection conferred by previous SARS-CoV-2 infection and by BNT162b2 vaccine: a 3-month nationwide experience from Israel. Am J Epidemiol. 2022;191(8):1420\u20138. https:\/\/doi.org\/10.1093\/aje\/kwac060.","journal-title":"Am J Epidemiol"},{"issue":"10","key":"4490_CR12","doi-asserted-by":"publisher","first-page":"e19102","DOI":"10.7759\/cureus.19102","volume":"13","author":"MB Shenai","year":"2021","unstructured":"Shenai MB, Rahme R, Noorchashm H. Equivalency of Protection From Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis. Cureus. 2021;13(10):e19102. https:\/\/doi.org\/10.7759\/cureus.19102.","journal-title":"Cureus"},{"issue":"7","key":"4490_CR13","doi-asserted-by":"publisher","first-page":"11180","DOI":"10.1021\/acsnano.1c03972","volume":"15","author":"FJ Ibarrondo","year":"2021","unstructured":"Ibarrondo FJ, Hofmann C, Fulcher JA, Goodman-Meza D, Mu W, Hausner MA, et al. Primary, recall, and decay kinetics of SARS-CoV-2 vaccine antibody responses. ACS Nano. 2021;15(7):11180\u201391. https:\/\/doi.org\/10.1021\/acsnano.1c03972.","journal-title":"ACS Nano"},{"issue":"13","key":"4490_CR14","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","volume":"386","author":"V Hall","year":"2022","unstructured":"Hall V, Foulkes S, Insalata F, Kirwan P, Saei A, Atti A, et al. Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection. N Engl J Med. 2022;386(13):1207\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2118691.","journal-title":"N Engl J Med"},{"issue":"13","key":"4490_CR15","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa2119497","volume":"386","author":"A Hammerman","year":"2022","unstructured":"Hammerman A, Sergienko R, Friger M, Beckenstein T, Peretz A, Netzer D, et al. Effectiveness of the BNT162b2 vaccine after recovery from Covid-19. N Engl J Med. 2022;386(13):1221\u20139. https:\/\/doi.org\/10.1056\/NEJMoa2119497.","journal-title":"N Engl J Med"},{"issue":"2","key":"4490_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020370","volume":"11","author":"JR Spinardi","year":"2023","unstructured":"Spinardi JR, Srivastava A. Hybrid immunity to SARS-CoV-2 from infection and vaccination\u2014evidence synthesis and implications for new COVID-19 vaccines. Biomedicines. 2023;11(2):370. https:\/\/doi.org\/10.3390\/biomedicines11020370.","journal-title":"Biomedicines"},{"issue":"1","key":"4490_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02231-x","volume":"20","author":"R Rose","year":"2022","unstructured":"Rose R, Neumann F, Grobe O, Lorentz T, Fickenscher H, Krumbholz A. Humoral immune response after different SARS-CoV-2 vaccination regimens. BMC Med. 2022;20(1):31. https:\/\/doi.org\/10.1186\/s12916-021-02231-x.","journal-title":"BMC Med"},{"key":"4490_CR18","doi-asserted-by":"publisher","unstructured":"Goel RR, Apostolidis SA, Painter MM, Mathew D, Pattekar A, Kuthuru O, et\u00a0al. Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals after mRNA vaccination. Science Immunology. 2021;6(58):eabi6950. Publisher: American Association for the Advancement of Science. https:\/\/doi.org\/10.1126\/sciimmunol.abi6950.","DOI":"10.1126\/sciimmunol.abi6950"},{"key":"4490_CR19","doi-asserted-by":"publisher","unstructured":"Abd-alrazaq A, Nashwan AJ, Shah Z, Abujaber A, Alhuwail D, Schneider J, et\u00a0al. Machine Learning\u2013Based Approach for Identifying Research Gaps: COVID-19 as a Case Study. JMIR Formative Research. 2024;8(1):e49411. Publisher: JMIR Publications Inc., Toronto, Canada. https:\/\/doi.org\/10.2196\/49411.","DOI":"10.2196\/49411"},{"issue":"9","key":"4490_CR20","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nri891","volume":"2","author":"DR Burton","year":"2002","unstructured":"Burton DR. Antibodies, viruses and vaccines. Nat Rev Immunol. 2002;2(9):706\u201313. https:\/\/doi.org\/10.1038\/nri891.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"4490_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41577-020-0359-5","volume":"20","author":"T Zohar","year":"2020","unstructured":"Zohar T, Alter G, Nature Publishing Group. Dissecting antibody-mediated protection against SARS-CoV-2. Nat Rev Immunol. 2020;20(7):392\u20134. https:\/\/doi.org\/10.1038\/s41577-020-0359-5.","journal-title":"Nat Rev Immunol"},{"key":"4490_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01677","author":"HO Padilla-Quirarte","year":"2019","unstructured":"Padilla-Quirarte HO, Lopez-Guerrero DV, Gutierrez-Xicotencatl L, Esquivel-Guadarrama F. Protective antibodies against influenza proteins. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.01677.","journal-title":"Front Immunol"},{"key":"4490_CR23","doi-asserted-by":"publisher","unstructured":"Forthal DN. Functions of Antibodies. Microbiology Spectrum. 2014;2(4):10.1128\/microbiolspec.aid\u20130019\u20132014. Publisher: American Society for Microbiology. https:\/\/doi.org\/10.1128\/microbiolspec.aid-0019-2014.","DOI":"10.1128\/microbiolspec.aid-0019-2014"},{"issue":"3","key":"4490_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0952-7915(98)80162-3","volume":"10","author":"MK Slifka","year":"1998","unstructured":"Slifka MK, Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol. 1998;10(3):252\u20138. https:\/\/doi.org\/10.1016\/S0952-7915(98)80162-3.","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"4490_CR25","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/infdis\/jiu219","volume":"210","author":"MT White","year":"2014","unstructured":"White MT, Griffin JT, Akpogheneta O, Conway DJ, Koram KA, Riley EM, et al. Dynamics of the antibody response to Plasmodium falciparum infection in African children. J Infect Dis. 2014;210(7):1115\u201322. https:\/\/doi.org\/10.1093\/infdis\/jiu219.","journal-title":"J Infect Dis"},{"issue":"3","key":"4490_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002418","volume":"8","author":"M Andraud","year":"2012","unstructured":"Andraud M, Lejeune O, Musoro JZ, Ogunjimi B, Beutels P, Hens N. Living on three time scales: the dynamics of plasma cell and antibody populations illustrated for Hepatitis A virus. PLoS Comput Biol. 2012;8(3):e1002418. https:\/\/doi.org\/10.1371\/journal.pcbi.1002418.","journal-title":"PLoS Comput Biol"},{"key":"4490_CR27","doi-asserted-by":"crossref","unstructured":"Le D, Miller JD, Ganusov VV. Mathematical modeling provides kinetic details of the human immune response to vaccination. Front Cell Infect\u00a0Microbiol\u00a02015;4.","DOI":"10.3389\/fcimb.2014.00177"},{"issue":"12","key":"4490_CR28","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1093\/cid\/ciab219","volume":"73","author":"J Van Elslande","year":"2021","unstructured":"Van Elslande J, Gruwier L, Godderis L, Vermeersch P. Estimated half-life of SARS-CoV-2 anti-spike antibodies more than double the half-life of anti-nucleocapsid antibodies in healthcare workers. Clin Infect Dis. 2021;73(12):2366\u20138. https:\/\/doi.org\/10.1093\/cid\/ciab219.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4490_CR29","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.chom.2021.04.015","volume":"29","author":"K Vanshylla","year":"2021","unstructured":"Vanshylla K, Di Cristanziano V, Kleipass F, Dewald F, Schommers P, Gieselmann L, et al. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans. Cell Host & Microbe. 2021;29(6):917-929.e4. https:\/\/doi.org\/10.1016\/j.chom.2021.04.015.","journal-title":"Cell Host & Microbe"},{"key":"4490_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1097747","volume":"14","author":"FJ Cimas","year":"2023","unstructured":"Cimas FJ, Torres J, Onta\u00f1\u00f3n J, de Cabo C, Lozano J, Requena MA, et al. Mathematical modeling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination. Front Immunol. 2023;14:1097747. https:\/\/doi.org\/10.3389\/fimmu.2023.1097747.","journal-title":"Front Immunol"},{"issue":"3","key":"4490_CR31","doi-asserted-by":"publisher","first-page":"e1261","DOI":"10.1002\/cti2.1261","volume":"10","author":"AL Whitcombe","year":"2021","unstructured":"Whitcombe AL, McGregor R, Craigie A, James A, Charlewood R, Lorenz N, et al. Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand. Clinical & Translational Immunology. 2021;10(3):e1261. https:\/\/doi.org\/10.1002\/cti2.1261.","journal-title":"Clinical & Translational Immunology"},{"issue":"7","key":"4490_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071184","volume":"11","author":"R Yorsaeng","year":"2023","unstructured":"Yorsaeng R, Atsawawaranunt K, Suntronwong N, Kanokudom S, Chansaenroj J, Assawakosri S, et al. SARS-CoV-2 antibody dynamics after COVID-19 vaccination and infection: a real-world cross-sectional analysis. Vaccines. 2023;11(7):1184. https:\/\/doi.org\/10.3390\/vaccines11071184.","journal-title":"Vaccines"},{"issue":"3","key":"4490_CR33","doi-asserted-by":"publisher","first-page":"e699","DOI":"10.1093\/cid\/ciab004","volume":"73","author":"SF Lumley","year":"2021","unstructured":"Lumley SF, Wei J, O\u2019Donnell D, Stoesser NE, Matthews PC, Howarth A, et al. The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers. Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America. 2021;73(3):e699\u2013709. https:\/\/doi.org\/10.1093\/cid\/ciab004.","journal-title":"Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America"},{"key":"4490_CR34","doi-asserted-by":"publisher","unstructured":"Chen Y, Tong P, Whiteman N, Sanjari\u00a0Moghaddam A, Zarghami M, Zuiani A, et\u00a0al. Immune recall improves antibody durability and breadth to SARS-CoV-2 variants. Sci\u00a0Immunol. 2022;7(78):eabp8328. Publisher: American Association for the Advancement of Science. https:\/\/doi.org\/10.1126\/sciimmunol.abp8328.","DOI":"10.1126\/sciimmunol.abp8328"},{"issue":"7","key":"4490_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100354","volume":"2","author":"KW Cohen","year":"2021","unstructured":"Cohen KW, Linderman SL, Moodie Z, Czartoski J, Lai L, Mantus G, et al. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep Med. 2021;2(7):100354. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100354.","journal-title":"Cell Rep Med"},{"issue":"7","key":"4490_CR36","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/cid\/ciab607","volume":"74","author":"L Grandjean","year":"2022","unstructured":"Grandjean L, Saso A, Torres Ortiz A, Lam T, Hatcher J, Thistlethwayte R, et al. Long-term persistence of spike protein antibody and predictive modeling of antibody dynamics after infection with severe acute respiratory syndrome coronavirus 2. Clin Infect Dis. 2022;74(7):1220\u20139. https:\/\/doi.org\/10.1093\/cid\/ciab607.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4490_CR37","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/S2666-5247(20)30197-X","volume":"2","author":"J Rosado","year":"2021","unstructured":"Rosado J, Pelleau S, Cockram C, Merkling SH, Nekkab N, Demeret C, et al. Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study. The Lancet Microbe. 2021;2(2):e60\u20139. https:\/\/doi.org\/10.1016\/S2666-5247(20)30197-X.","journal-title":"The Lancet Microbe"},{"issue":"222","key":"4490_CR38","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2024.0445","volume":"22","author":"D Stocks","year":"2025","unstructured":"Stocks D, Thomas A, Finn A, Danon L, Brooks-Pollock E. Mechanistic models of humoral kinetics following COVID-19 vaccination. J R Soc Interface. 2025;22(222):20240445. https:\/\/doi.org\/10.1098\/rsif.2024.0445.","journal-title":"J R Soc Interface"},{"issue":"52","key":"4490_CR39","doi-asserted-by":"publisher","first-page":"7655","DOI":"10.1016\/j.vaccine.2023.11.040","volume":"41","author":"T Nishiyama","year":"2023","unstructured":"Nishiyama T, Miyamatsu Y, Park H, Nakamura N, Yokokawa Shibata R, Iwami S, et al. Modeling COVID-19 vaccine booster-elicited antibody response and impact of infection history. Vaccine. 2023;41(52):7655\u201362. https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.040.","journal-title":"Vaccine"},{"key":"4490_CR40","doi-asserted-by":"publisher","unstructured":"Deichmann J, Barda N, Canetti M, Peretz Y, Weiss-Ottolenghi Y, Lustig Y, et\u00a0al. Predicting antibody kinetics and duration of protection against SARS-CoV-2 following vaccination from sparse serological data. PLOS Comput Biol. 2025;21(6):e1013192. Publisher: Public Library of Science. https:\/\/doi.org\/10.1371\/journal.pcbi.1013192.","DOI":"10.1371\/journal.pcbi.1013192"},{"issue":"2","key":"4490_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2024.105423","volume":"27","author":"R Rubio","year":"2025","unstructured":"Rubio R, Maci\u00e0 D, Barrios D, Vidal M, Jim\u00e9nez A, Molinos-Albert LM, et al. High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination. Microbes Infect. 2025;27(2):105423. https:\/\/doi.org\/10.1016\/j.micinf.2024.105423.","journal-title":"Microbes Infect"},{"key":"4490_CR42","doi-asserted-by":"crossref","unstructured":"Eriksson EM, Hart A, Forde M, Foroughi S, Kiernan-Walker N, Mazhari R, et\u00a0al. Cohort Profile: A longitudinal Victorian COVID-19 cohort (COVID PROFILE). Infect Dis (except HIV\/AIDS). 2023. http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.04.27.23289157.","DOI":"10.1101\/2023.04.27.23289157"},{"issue":"4","key":"4490_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/mps4040072","volume":"4","author":"R Mazhari","year":"2021","unstructured":"Mazhari R, Ruybal-Pes\u00e1ntez S, Angrisano F, Kiernan-Walker N, Hyslop S, Longley RJ, et al. SARS-CoV-2 multi-antigen serology assay. Methods and Protocols. 2021;4(4):72. https:\/\/doi.org\/10.3390\/mps4040072.","journal-title":"Methods and Protocols"},{"issue":"3","key":"4490_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1473-3099(18)30674-1","volume":"19","author":"M White","year":"2019","unstructured":"White M, Idoko O, Sow S, Diallo A, Kampmann B, Borrow R, et al. Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials. Lancet Infect Dis. 2019;19(3):327\u201336. https:\/\/doi.org\/10.1016\/S1473-3099(18)30674-1.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"4490_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02281-9","volume":"20","author":"ZSJ Liu","year":"2022","unstructured":"Liu ZSJ, Sattabongkot J, White M, Chotirat S, Kumpitak C, Takashima E, et al. Naturally acquired antibody kinetics against Plasmodium vivax antigens in people from a low malaria transmission region in western Thailand. BMC Med. 2022;20(1):89. https:\/\/doi.org\/10.1186\/s12916-022-02281-9.","journal-title":"BMC Med"},{"issue":"1","key":"4490_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01901-w","volume":"8","author":"E Hammarlund","year":"2017","unstructured":"Hammarlund E, Thomas A, Amanna IJ, Holden LA, Slayden OD, Park B, et al. Plasma cell survival in the absence of B cell memory. Nat Commun. 2017;8(1):1781. https:\/\/doi.org\/10.1038\/s41467-017-01901-w.","journal-title":"Nat Commun"},{"issue":"3","key":"4490_CR47","doi-asserted-by":"publisher","first-page":"839","DOI":"10.4049\/jimmunol.1700461","volume":"199","author":"JR Wilmore","year":"2017","unstructured":"Wilmore JR, Allman D. Here, there, and anywhere? Arguments for and against the physical plasma cell survival niche. J Immunol. 2017;199(3):839\u201345. https:\/\/doi.org\/10.4049\/jimmunol.1700461.","journal-title":"J Immunol"},{"issue":"2","key":"4490_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.imlet.2005.09.009","volume":"103","author":"K Moser","year":"2006","unstructured":"Moser K, Muehlinghaus G, Manz R, Mei H, Voigt C, Yoshida T, et al. Long-lived plasma cells in immunity and immunopathology. Immunol Lett. 2006;103(2):83\u20135. https:\/\/doi.org\/10.1016\/j.imlet.2005.09.009.","journal-title":"Immunol Lett"},{"issue":"12","key":"4490_CR49","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.4049\/jimmunol.1103720","volume":"189","author":"M Cocco","year":"2012","unstructured":"Cocco M, Stephenson S, Care MA, Newton D, Barnes NA, Davison A, et al. In vitro generation of long-lived human plasma cells. J Immunol. 2012;189(12):5773\u201385. https:\/\/doi.org\/10.4049\/jimmunol.1103720.","journal-title":"J Immunol"},{"issue":"1","key":"4490_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46321-9","volume":"15","author":"S Foss","year":"2024","unstructured":"Foss S, Sakya SA, Aguinagalde L, Lustig M, Shaughnessy J, Cruz AR, et al. Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria. Nat Commun. 2024;15(1):2007. https:\/\/doi.org\/10.1038\/s41467-024-46321-9.","journal-title":"Nat Commun"},{"key":"4490_CR51","doi-asserted-by":"publisher","unstructured":"Saxena A, Wu D, Advances in Therapeutic Fc Engineering \u2013 Modulation of IgG-Associated Effector Functions and Serum Half-life. Front Immunol. 2016;7. Publisher: Frontiers. https:\/\/doi.org\/10.3389\/fimmu.2016.00580.","DOI":"10.3389\/fimmu.2016.00580"},{"issue":"4","key":"4490_CR52","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1172\/JCI106279","volume":"49","author":"A Morell","year":"1970","unstructured":"Morell A, Terry WD, Waldmann TA. Metabolic properties of IgG subclasses in man. J Clin Invest. 1970;49(4):673\u201380. https:\/\/doi.org\/10.1172\/JCI106279.","journal-title":"J Clin Invest"},{"issue":"2","key":"4490_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.103746","volume":"25","author":"A Grevys","year":"2022","unstructured":"Grevys A, Frick R, Mester S, Flem-Karlsen K, Nilsen J, Foss S, et al. Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life. iScience. 2022;25(2):103746. https:\/\/doi.org\/10.1016\/j.isci.2022.103746.","journal-title":"iScience"},{"issue":"6","key":"4490_CR54","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00482-21","volume":"60","author":"A Misra","year":"2022","unstructured":"Misra A, Theel ES, American Society for Microbiology. Immunity to SARS-CoV-2: what do we know and should we be testing for it? J Clin Microbiol. 2022;60(6):e00482\u201321. https:\/\/doi.org\/10.1128\/jcm.00482-21.","journal-title":"J Clin Microbiol"},{"key":"4490_CR55","unstructured":"Stan Development Team.: Prior Choice Recommendations. https:\/\/github.com\/stan-dev\/stan\/wiki\/Prior-Choice-Recommendations. Accessed 24 Feb 2025"},{"key":"4490_CR56","unstructured":"Stan Development Team.: RStan: the R interface to Stan. https:\/\/mc-stan.org\/. Accessed 12 Feb 2024"},{"key":"4490_CR57","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2024. https:\/\/www.R-project.org\/. Accessed 9 May 2025"},{"issue":"40","key":"4490_CR58","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01541","volume":"4","author":"D Makowski","year":"2019","unstructured":"Makowski D, Ben-Shachar MS, L\u00fcdecke D. BayestestR: describing effects and their uncertainty, existence and significance within the Bayesian framework. J Open Source Softw. 2019;4(40):1541. https:\/\/doi.org\/10.21105\/joss.01541.","journal-title":"J Open Source Softw"},{"key":"4490_CR59","unstructured":"Gabry J, Goodrich B, Lysy M, Johnson A. rstantools: Tools for Developing R Packages Interfacing with \u2018Stan\u2019. 2024. https:\/\/CRAN.R-project.org\/package=rstantools. Accessed 21 Apr 2025"},{"key":"4490_CR60","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.trsl.2021.10.004","volume":"240","author":"C Doba\u00f1o","year":"2022","unstructured":"Doba\u00f1o C, Jim\u00e9nez A, Rubio R, Alonso S, Ram\u00edrez-Morros A, Vidal M, et al. Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen. Transl Res. 2022;240:26\u201332. https:\/\/doi.org\/10.1016\/j.trsl.2021.10.004.","journal-title":"Transl Res"},{"key":"4490_CR61","doi-asserted-by":"publisher","unstructured":"Ruggiero A, Piubelli C, Calciano L, Accordini S, Valenti MT, Carbonare LD, et\u00a0al. SARS-CoV-2 vaccination elicits unconventional IgM specific responses in na\u00efve and previously COVID-19-infected individuals. eBioMedicine. 2022;77. Publisher: Elsevier. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103888.","DOI":"10.1016\/j.ebiom.2022.103888"},{"key":"4490_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1229716","author":"L Reynolds","year":"2023","unstructured":"Reynolds L, Dewey C, Asfour G, Little M. Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review. Front Public Health. 2023. https:\/\/doi.org\/10.3389\/fpubh.2023.1229716.","journal-title":"Front Public Health"},{"issue":"6","key":"4490_CR63","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41591-021-01325-6","volume":"27","author":"JE Ebinger","year":"2021","unstructured":"Ebinger JE, Fert-Bober J, Printsev I, Wu M, Sun N, Prostko JC, et al. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2. Nat Med. 2021;27(6):981\u20134. https:\/\/doi.org\/10.1038\/s41591-021-01325-6.","journal-title":"Nat Med"},{"issue":"14","key":"4490_CR64","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1056\/NEJMc2101667","volume":"384","author":"F Krammer","year":"2021","unstructured":"Krammer F, Srivastava K, Alshammary H, Amoako AA, Awawda MH, Beach KF, et al. Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine. N Engl J Med. 2021;384(14):1372\u20134. https:\/\/doi.org\/10.1056\/NEJMc2101667.","journal-title":"N Engl J Med"},{"issue":"3","key":"4490_CR65","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.medj.2023.02.004","volume":"4","author":"SC Moore","year":"2023","unstructured":"Moore SC, Kronsteiner B, Longet S, Adele S, Deeks AS, Liu C, et al. Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens. Med. 2023;4(3):191-215.e9. https:\/\/doi.org\/10.1016\/j.medj.2023.02.004.","journal-title":"Med."},{"issue":"10","key":"4490_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101163","volume":"9","author":"TC Ho","year":"2021","unstructured":"Ho TC, Chen YMA, Chan HP, Chang CC, Chuang KP, Lee CH, et al. The effects of heterologous immunization with prime-boost COVID-19 vaccination against SARS-CoV-2. Vaccines. 2021;9(10):1163. https:\/\/doi.org\/10.3390\/vaccines9101163.","journal-title":"Vaccines"},{"issue":"1","key":"4490_CR67","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1080\/22221751.2021.1957401","volume":"10","author":"J Zhang","year":"2021","unstructured":"Zhang J, He Q, An C, Mao Q, Gao F, Bian L, et al. Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine. Emerg Microbes Infect. 2021;10(1):1598\u2013608. https:\/\/doi.org\/10.1080\/22221751.2021.1957401.","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"4490_CR68","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2221146","volume":"19","author":"X Zhang","year":"2023","unstructured":"Zhang X, Xia J, Jin L, Wu Y, Zheng X, Cao X, et al. Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: a systematic review and meta-analysis. Hum Vaccin Immunother. 2023;19(2):2221146. https:\/\/doi.org\/10.1080\/21645515.2023.2221146.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"4490_CR69","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","volume":"3","author":"D Cromer","year":"2022","unstructured":"Cromer D, Steain M, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis. Lancet Microbe. 2022;3(1):e52\u201361. https:\/\/doi.org\/10.1016\/S2666-5247(21)00267-6.","journal-title":"Lancet Microbe"},{"issue":"11","key":"4490_CR70","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.cell.2022.04.009","volume":"185","author":"RR Goel","year":"2022","unstructured":"Goel RR, Painter MM, Lundgreen KA, Apostolidis SA, Baxter AE, Giles JR, et al. Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine. Cell. 2022;185(11):1875-1887.e8. https:\/\/doi.org\/10.1016\/j.cell.2022.04.009.","journal-title":"Cell"},{"issue":"9","key":"4490_CR71","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.cell.2022.03.018","volume":"185","author":"LB Rodda","year":"2022","unstructured":"Rodda LB, Morawski PA, Pruner KB, Fahning ML, Howard CA, Franko N, et al. Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity. Cell. 2022;185(9):1588-1601.e14. https:\/\/doi.org\/10.1016\/j.cell.2022.03.018.","journal-title":"Cell"},{"key":"4490_CR72","doi-asserted-by":"publisher","unstructured":"Lapuente D, Winkler TH, Tenbusch M. B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity. Cell Mol Immunol. 2024;21(2):144\u2013158. Publisher: Nature Publishing Group. https:\/\/doi.org\/10.1038\/s41423-023-01095-w.","DOI":"10.1038\/s41423-023-01095-w"},{"issue":"9","key":"4490_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12091051","volume":"12","author":"P Tsagkli","year":"2024","unstructured":"Tsagkli P, Geropeppa M, Papadatou I, Spoulou V. Hybrid immunity against SARS-CoV-2 variants: a narrative review of the literature. Vaccines. 2024;12(9):1051. https:\/\/doi.org\/10.3390\/vaccines12091051.","journal-title":"Vaccines"},{"issue":"18","key":"4490_CR74","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/j.vaccine.2016.03.003","volume":"34","author":"A Blommaert","year":"2016","unstructured":"Blommaert A, Bilcke J, Willem L, Verhaegen J, Goossens H, Beutels P. The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: an exploration of influential factors for Belgium. Vaccine. 2016;34(18):2106\u201312. https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.003.","journal-title":"Vaccine"},{"key":"4490_CR75","unstructured":"The World Health Organization.: WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines: An approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2023.1. Accessed 2 Apr 2025"},{"issue":"1","key":"4490_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21444-5","volume":"12","author":"AK Wheatley","year":"2021","unstructured":"Wheatley AK, Juno JA, Wang JJ, Selva KJ, Reynaldi A, Tan HX, et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat Commun. 2021;12(1):1162. https:\/\/doi.org\/10.1038\/s41467-021-21444-5.","journal-title":"Nat Commun"},{"issue":"7867","key":"4490_CR77","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41586-021-03647-4","volume":"595","author":"JS Turner","year":"2021","unstructured":"Turner JS, Kim W, Kalaidina E, Goss CW, Rauseo AM, Schmitz AJ, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595(7867):421\u20135. https:\/\/doi.org\/10.1038\/s41586-021-03647-4.","journal-title":"Nature"},{"issue":"24","key":"4490_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10245882","volume":"10","author":"I Mamais","year":"2021","unstructured":"Mamais I, Malatras A, Papagregoriou G, Giallourou N, Kakouri AC, Karayiannis P, et al. Circulating IgG levels in SARS-CoV-2 convalescent individuals in Cyprus. J Clin Med. 2021;10(24):5882. https:\/\/doi.org\/10.3390\/jcm10245882.","journal-title":"J Clin Med"},{"issue":"4","key":"4490_CR79","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","volume":"20","author":"M Akkaya","year":"2020","unstructured":"Akkaya M, Kwak K, Pierce SK. B cell memory: building two walls of protection against pathogens. Nat Rev Immunol. 2020;20(4):229\u201338. https:\/\/doi.org\/10.1038\/s41577-019-0244-2.","journal-title":"Nat Rev Immunol"},{"key":"4490_CR80","unstructured":"Charles A\u00a0Janeway J, Travers P, Walport M, Shlomchik MJ. Immunological memory. In: Immunobiology: The Immune System in Health and Disease. 5th ed. Garland Science; 2001. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK27158\/. Accessed 31 Oct 2024"},{"issue":"1","key":"4490_CR81","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/eji.201847517","volume":"49","author":"J Tellier","year":"2019","unstructured":"Tellier J, Nutt SL. Plasma cells: the programming of an antibody-secreting machine. Eur J Immunol. 2019;49(1):30\u20137. https:\/\/doi.org\/10.1002\/eji.201847517.","journal-title":"Eur J Immunol"},{"key":"4490_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01787","author":"AKE Palm","year":"2019","unstructured":"Palm AKE, Henry C. Remembrance of things past: long-term B cell memory after infection and vaccination. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.01787.","journal-title":"Front Immunol"},{"key":"4490_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2024.101551","volume":"63","author":"M Bachmann","year":"2025","unstructured":"Bachmann M, G\u00fcltekin N, Stanga Z, Fehr JS, \u00dclg\u00fcr II, Schlagenhauf P. Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: a systematic review. New Microbes New Infect. 2025;63:101551. https:\/\/doi.org\/10.1016\/j.nmni.2024.101551.","journal-title":"New Microbes New Infect"},{"issue":"3","key":"4490_CR84","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4302","volume":"4","author":"HS Yang","year":"2021","unstructured":"Yang HS, Costa V, Racine-Brzostek SE, Acker KP, Yee J, Chen Z, et al. Association of age with SARS-CoV-2 antibody response. JAMA Netw Open. 2021;4(3):e214302. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.4302.","journal-title":"JAMA Netw Open"},{"key":"4490_CR85","doi-asserted-by":"publisher","unstructured":"Collier DA, Ferreira IATM, Kotagiri P, Datir RP, Lim EY, Touizer E, et\u00a0al. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature. 2021;596(7872):417\u2013422. Publisher: Nature Publishing Group. https:\/\/doi.org\/10.1038\/s41586-021-03739-1.","DOI":"10.1038\/s41586-021-03739-1"},{"issue":"1821","key":"4490_CR86","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2014.3085","volume":"282","author":"AK Simon","year":"2015","unstructured":"Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc R Soc Lond B Biol Sci. 2015;282(1821):20143085. https:\/\/doi.org\/10.1098\/rspb.2014.3085.","journal-title":"Proc R Soc Lond B Biol Sci"},{"issue":"4","key":"4490_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12040775","volume":"12","author":"E Quiros-Roldan","year":"2024","unstructured":"Quiros-Roldan E, Sottini A, Natali PG, Imberti L. The impact of immune system aging on infectious diseases. Microorganisms. 2024;12(4):775. https:\/\/doi.org\/10.3390\/microorganisms12040775.","journal-title":"Microorganisms"},{"issue":"2","key":"4490_CR88","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13083","volume":"19","author":"CSL Tuttle","year":"2020","unstructured":"Tuttle CSL, Waaijer MEC, Slee-Valentijn MS, Stijnen T, Westendorp R, Maier AB. Cellular senescence and chronological age in various human tissues: a systematic review and meta-analysis. Aging Cell. 2020;19(2):e13083. https:\/\/doi.org\/10.1111\/acel.13083.","journal-title":"Aging Cell"},{"issue":"2","key":"4490_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009165","volume":"15","author":"J Rosado","year":"2021","unstructured":"Rosado J, White MT, Longley RJ, Lacerda M, Monteiro W, Brewster J, et al. Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts. PLoS Negl Trop Dis. 2021;15(2):e0009165. https:\/\/doi.org\/10.1371\/journal.pntd.0009165.","journal-title":"PLoS Negl Trop Dis"},{"key":"4490_CR90","unstructured":"Administration\u00a0(TGA) TG.: COVID-19 vaccines regulatory status | Therapeutic Goods Administration (TGA) [text]. Publisher: Therapeutic Goods Administration (TGA). https:\/\/www.tga.gov.au\/products\/covid-19\/covid-19-vaccines\/covid-19-vaccines-regulatory-status. Accessed 15 Jul 2025"},{"issue":"1","key":"4490_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01129-6","volume":"10","author":"MC Trieu","year":"2025","unstructured":"Trieu MC, Reynaldi A, Lee WS, Tan HX, Kelly A, Esterbauer R, et al. Bivalent mRNA booster vaccination recalls cellular and antibody immunity against antigenically divergent SARS-CoV-2 spike antigens. NPJ Vaccines. 2025;10(1):74. https:\/\/doi.org\/10.1038\/s41541-025-01129-6.","journal-title":"NPJ Vaccines"},{"key":"4490_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101668","author":"WN Voss","year":"2024","unstructured":"Voss WN, Mallory ML, Byrne PO, Marchioni JM, Knudson SA, Powers JM. Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination. Cell Rep Med. 2024. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101668.","journal-title":"Cell Rep Med"},{"key":"4490_CR93","doi-asserted-by":"publisher","unstructured":"Reynolds CJ, Gibbons JM, Pade C, Lin KM, Sandoval DM, Pieper F, et\u00a0al. Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants. Science. 2022;375(6577):183\u2013192. Publisher: American Association for the Advancement of Science. https:\/\/doi.org\/10.1126\/science.abm0811.","DOI":"10.1126\/science.abm0811"},{"key":"4490_CR94","doi-asserted-by":"publisher","unstructured":"Wheatley AK, Fox A, Tan HX, Juno JA, Davenport MP, Subbarao K, et\u00a0al. Immune imprinting and SARS-CoV-2 vaccine design. Trends Immunol. 2021;42(11):956\u2013959. Publisher: Elsevier. https:\/\/doi.org\/10.1016\/j.it.2021.09.001.","DOI":"10.1016\/j.it.2021.09.001"},{"issue":"11","key":"4490_CR95","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41564-023-01505-9","volume":"8","author":"CQ Huang","year":"2023","unstructured":"Huang CQ, Vishwanath S, Carnell GW, Chan ACY, Heeney JL. Immune imprinting and next-generation coronavirus vaccines. Nat Microbiol. 2023;8(11):1971\u201385. https:\/\/doi.org\/10.1038\/s41564-023-01505-9.","journal-title":"Nat Microbiol"},{"issue":"5","key":"4490_CR96","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.immuni.2023.04.012","volume":"56","author":"M Koutsakos","year":"2023","unstructured":"Koutsakos M, Ellebedy AH. Immunological imprinting: understanding COVID-19. Immunity. 2023;56(5):909\u201313. https:\/\/doi.org\/10.1016\/j.immuni.2023.04.012.","journal-title":"Immunity"},{"key":"4490_CR97","doi-asserted-by":"publisher","unstructured":"Johnston TS, Li SH, Painter MM, Atkinson RK, Douek NR, Reeg DB, et\u00a0al. Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants. Immunity. 2024;57(4):912\u2013925.e4. Publisher: Elsevier. https:\/\/doi.org\/10.1016\/j.immuni.2024.02.017.","DOI":"10.1016\/j.immuni.2024.02.017"},{"key":"4490_CR98","doi-asserted-by":"publisher","unstructured":"Torresi J, Edeling MA. Immune imprinting of SARS-CoV-2 responses: changing first immune impressions. mSphere. 2024;9(4):e00758\u201323. Publisher: American Society for Microbiology. https:\/\/doi.org\/10.1128\/msphere.00758-23.","DOI":"10.1128\/msphere.00758-23"},{"issue":"7","key":"4490_CR99","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27(7):1205\u201311. https:\/\/doi.org\/10.1038\/s41591-021-01377-8.","journal-title":"Nat Med"},{"issue":"1","key":"4490_CR100","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.13091","volume":"310","author":"D Goldblatt","year":"2022","unstructured":"Goldblatt D, Alter G, Crotty S, Plotkin SA. Correlates of protection against SARS-CoV-2 infection and COVID-19 disease. Immunol Rev. 2022;310(1):6\u201326. https:\/\/doi.org\/10.1111\/imr.13091.","journal-title":"Immunol Rev"},{"issue":"2","key":"4490_CR101","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3201\/eid2902.221422","volume":"29","author":"DS Khoury","year":"2023","unstructured":"Khoury DS, Schlub TE, Cromer D, Steain M, Fong Y, Gilbert PB, et al. Correlates of protection, thresholds of protection, and immunobridging among persons with SARS-CoV-2 infection. Emerg Infect Dis. 2023;29(2):381\u20138. https:\/\/doi.org\/10.3201\/eid2902.221422.","journal-title":"Emerg Infect Dis"},{"key":"4490_CR102","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13531","author":"W Chen","year":"2022","unstructured":"Chen W, Zhang L, Li J, Bai S, Wang Y, Zhang B, et al. The kinetics of IgG subclasses and contributions to neutralizing activity against SARS-CoV-2 wild-type strain and variants in healthy adults immunized with inactivated vaccine. Immunology. 2022. https:\/\/doi.org\/10.1111\/imm.13531.","journal-title":"Immunology"},{"issue":"1","key":"4490_CR103","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/jmv.27287","volume":"94","author":"R Dolscheid-Pommerich","year":"2022","unstructured":"Dolscheid-Pommerich R, Bartok E, Renn M, K\u00fcmmerer BM, Schulte B, Schmithausen RM, et al. Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and neutralization activity. J Med Virol. 2022;94(1):388\u201392. https:\/\/doi.org\/10.1002\/jmv.27287.","journal-title":"J Med Virol"},{"key":"4490_CR104","doi-asserted-by":"publisher","unstructured":"Higashimoto Y, Kozawa K, Miura H, Kawamura Y, Ihira M, Hiramatsu H, et\u00a0al. Correlation between anti-S IgG and neutralizing antibody titers against three live SARS-CoV-2 variants in BNT162b2 vaccine recipients. Hum Vaccines Immunotherapeutics. 2022;18(6):2105611. Publisher: Taylor & Francis. https:\/\/doi.org\/10.1080\/21645515.2022.2105611.","DOI":"10.1080\/21645515.2022.2105611"},{"issue":"1","key":"4490_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12010205","volume":"12","author":"A Ramos","year":"2022","unstructured":"Ramos A, Cardoso MJ, Ribeiro L, Guimar\u00e3es JT. Assessing SARS-CoV-2 neutralizing antibodies after BNT162b2 vaccination and their correlation with SARS-CoV-2 IgG anti-S1, anti-RBD and anti-S2 serological titers. Diagnostics. 2022;12(1):205. https:\/\/doi.org\/10.3390\/diagnostics12010205.","journal-title":"Diagnostics"},{"issue":"1","key":"4490_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18450-4","volume":"11","author":"AT Huang","year":"2020","unstructured":"Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick LC, Rattigan SM, et al. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat Commun. 2020;11(1):4704. https:\/\/doi.org\/10.1038\/s41467-020-18450-4.","journal-title":"Nat Commun"},{"issue":"2","key":"4490_CR107","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.vaccine.2021.12.006","volume":"40","author":"D Goldblatt","year":"2022","unstructured":"Goldblatt D, Fiore-Gartland A, Johnson M, Hunt A, Bengt C, Zavadska D, et al. Towards a population-based threshold of protection for COVID-19 vaccines. Vaccine. 2022;40(2):306\u201315. https:\/\/doi.org\/10.1016\/j.vaccine.2021.12.006.","journal-title":"Vaccine"},{"issue":"1","key":"4490_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42717-1","volume":"14","author":"G Kenny","year":"2023","unstructured":"Kenny G, O\u2019Reilly S, Wrigley Kelly N, Negi R, Gaillard C, Alalwan D, et al. Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time. Nat Commun. 2023;14(1):7015. https:\/\/doi.org\/10.1038\/s41467-023-42717-1.","journal-title":"Nat Commun"},{"issue":"4","key":"4490_CR109","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01333-24","volume":"13","author":"A Nouanesengsy","year":"2025","unstructured":"Nouanesengsy A, Semesi A, Quach K, Ivanochko D, Byrne W, Hwang M, et al. Persistence and decay of neutralizing antibody responses elicited by SARS-CoV-2 infection and hybrid immunity in a Canadian cohort. Microbiol Spectr. 2025;13(4):e01333\u201324. https:\/\/doi.org\/10.1128\/spectrum.01333-24.","journal-title":"Microbiol Spectr"},{"issue":"18","key":"4490_CR110","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1001\/jama.2021.4388","volume":"325","author":"VV Edara","year":"2021","unstructured":"Edara VV, Hudson WH, Xie X, Ahmed R, Suthar MS. Neutralizing antibodies against SARS-CoV-2 variants after infection and vaccination. JAMA. 2021;325(18):1896\u20138. https:\/\/doi.org\/10.1001\/jama.2021.4388.","journal-title":"JAMA"},{"issue":"8","key":"4490_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007294","volume":"15","author":"JA Hay","year":"2019","unstructured":"Hay JA, Laurie K, White M, Riley S. Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets. PLoS Comput Biol. 2019;15(8):e1007294. https:\/\/doi.org\/10.1371\/journal.pcbi.1007294.","journal-title":"PLoS Comput Biol"},{"key":"4490_CR112","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jtbi.2016.11.008","volume":"413","author":"AWC Yan","year":"2017","unstructured":"Yan AWC, Cao P, Heffernan JM, McVernon J, Quinn KM, La Gruta NL, et al. Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host. J Theor Biol. 2017;413:34\u201349. https:\/\/doi.org\/10.1016\/j.jtbi.2016.11.008.","journal-title":"J Theor Biol"},{"key":"4490_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.epidem.2014.08.002","volume":"9","author":"WF de Graaf","year":"2014","unstructured":"de Graaf WF, Kretzschmar MEE, Teunis PFM, Diekmann O. A two-phase within-host model for immune response and its application to serological profiles of pertussis. Epidemics. 2014;9:1\u20137. https:\/\/doi.org\/10.1016\/j.epidem.2014.08.002.","journal-title":"Epidemics"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04490-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04490-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04490-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:21:03Z","timestamp":1767028863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-025-04490-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4490"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04490-4","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All COVID PROFILE study participants provided written informed consent as per the Declaration of Helsinki. The COVID PROFILE study was approved by the Walter and Eliza Hall Institute (Projects 20\/08) and the Melbourne Health Human Research Committees (RMH69108).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"705"}}